These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1524961)

  • 21. Development and Clinical Application of a Prednisolone/Cortisol Assay to Determine Adherence to Maintenance Oral Prednisolone in Severe Asthma.
    Mansur AH; Hassan M; Duffy J; Webster C
    Chest; 2020 Sep; 158(3):901-912. PubMed ID: 32298734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.
    Hovi T; Josefsson K; Renkonen OV
    Eur J Clin Pharmacol; 1983; 25(2):271-3. PubMed ID: 6628511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prednisolone levels in the plasma and urine: a study of two preparations in man.
    English J; Chakraborty J; Marks V; Trigger DJ; Thomson AG
    Br J Clin Pharmacol; 1975 Aug; 2(4):327-32. PubMed ID: 1233992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Eudragit-coated prednisolone preparation for ulcerative colitis: pharmacokinetics and preliminary therapeutic use.
    Ford GA; Oliver PS; Shepherd NA; Wilkinson SP
    Aliment Pharmacol Ther; 1992 Feb; 6(1):31-40. PubMed ID: 1543815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of plasma levels of prednisolone after oral administration in man.
    Leclercq R; Copinschi G
    J Pharmacokinet Biopharm; 1974 Apr; 2(2):175-87. PubMed ID: 4427221
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-absorption of enteric-coated prednisolone. Normal absorption of non-enteric-coated prednisolone in a patient with Crohn's disease and massive intestinal resection.
    Olivesi A
    Therapie; 1985; 40(1):5-7. PubMed ID: 4002184
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of two oral prednisolone tablet formulations in healthy volunteers.
    Luippold G; Schneider S; Marto M; Benöhr P; Mühlbauer B
    Arzneimittelforschung; 2001 Nov; 51(11):911-5. PubMed ID: 11765593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate].
    Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H
    Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of menthol and carvone after administration of an enteric coated formulation containing peppermint oil and caraway oil.
    Mascher H; Kikuta C; Schiel H
    Arzneimittelforschung; 2001; 51(6):465-9. PubMed ID: 11455677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enteric-coated and plain naproxen tablets in osteoarthritis; tolerability and efficacy.
    Lehn OF; Jensen ON; Andersen LA; Christensen KA; Solheim L; Barslev J; Mjølstad W; Wiig G; Ibfelt HH; Kjønniksen T
    Eur J Rheumatol Inflamm; 1992; 12(2):31-6. PubMed ID: 1364936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
    Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
    Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
    Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
    J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption of enteric-coated prednisolone.
    West HF
    Br Med J; 1979 Jun; 1(6180):1795-6. PubMed ID: 466234
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans.
    Ibekwe VC; Liu F; Fadda HM; Khela MK; Evans DF; Parsons GE; Basit AW
    J Pharm Sci; 2006 Dec; 95(12):2760-6. PubMed ID: 16917845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.